Introduction: The Growing Threat of Pharmaceutical Residues in Water

The presence of pharmaceutical contaminants in water supplies has emerged as one of the most pressing environmental and public health challenges of the 21st century. Traces of antibiotics, hormones, painkillers, antidepressants, and other active pharmaceutical ingredients (APIs) are now routinely detected in surface water, groundwater, and even treated drinking water worldwide. These compounds enter the water cycle through multiple pathways: improper disposal of unused medications, excretion after human or veterinary use, runoff from agriculture, and effluent discharges from pharmaceutical manufacturing facilities. Even at trace concentrations (nanograms to micrograms per liter), chronic exposure to pharmaceutical residues has been linked to endocrine disruption in aquatic organisms, the proliferation of antibiotic-resistant bacteria, and potential long-term health effects in humans. Conventional water treatment processes, such as coagulation, sedimentation, and sand filtration, are often inadequate for removing these persistent organic micropollutants. As regulatory limits tighten and public awareness grows, advanced oxidation technologies—particularly ozonation—have attracted intense interest for their ability to degrade pharmaceutical compounds effectively.

The Chemistry of Ozonation: An Overview

Ozonation is a chemical water treatment method that relies on ozone (O3), a triatomic molecule with exceptional oxidizing power. Ozone is a pale blue gas with a characteristic pungent odor, and it is the second most potent oxidant known after fluorine. Its standard reduction potential (2.07 V) makes it far more reactive than chlorine (1.36 V) or hydrogen peroxide (1.78 V). When ozone is dissolved in water, it can react with contaminants through two primary pathways: direct molecular oxidation and indirect radical-mediated oxidation. The direct pathway involves the selective attack of ozone molecules on specific functional groups such as double bonds, activated aromatic rings, and amines. The indirect pathway occurs when ozone decomposes in water to form hydroxyl radicals (•OH), which are even more powerful oxidizing species (2.80 V) that react non-selectively with virtually any organic molecule. The balance between these pathways depends on water chemistry parameters including pH, temperature, alkalinity, and the presence of natural organic matter (NOM). Ozone is generated on-site, typically by corona discharge (passing dry air or oxygen through a high-voltage electric field) or by ultraviolet (UV) irradiation, and then injected into the water stream via bubble diffusers, venturi injectors, or static mixers.

Ozone Generation Methods

Industrial ozone generators primarily use corona discharge technology, which produces ozone by applying a high-voltage alternating current across a discharge gap containing oxygen or air. The process yields up to 6-12% ozone by weight when using oxygen feed gas. More compact systems employ UV generation, where low-pressure mercury lamps (185 nm) split oxygen molecules to form ozone, but this method produces lower concentrations (0.1-1% by weight) and is more suited to small-scale applications. Electrochemical ozonolysis is an emerging alternative that generates ozone directly from water, avoiding the need for feed gas handling. Regardless of the method, on-site generation eliminates storage and transport hazards associated with ozone’s instability.

Mechanisms of Pharmaceutical Degradation by Ozone

Pharmaceutical molecules exhibit remarkable structural diversity, but most contain electron-rich moieties that are susceptible to ozone attack. Ozone preferentially reacts with unsaturated carbon-carbon bonds, aromatic systems (especially those activated by electron-donating groups such as hydroxyl or methoxy groups), amine functionalities, and sulfur-containing groups. Hydroxyl radicals formed during ozone decomposition can then attack any residual organic matter, including recalcitrant compounds that ozone itself oxidizes slowly.

Direct Ozone Oxidation Pathways

For many common pharmaceutical families, direct ozone attack proceeds via cycloaddition (Criegee mechanism) on double bonds or via electrophilic substitution on aromatic rings. For example, the antibiotic sulfamethoxazole contains an isoxazole ring with a C=C double bond that is rapidly cleaved by ozone. The anti-inflammatory drug diclofenac has an aniline structure that reacts quickly with ozone at the aromatic ring. Similarly, the hormone 17α-ethinylestradiol (EE2), a potent synthetic estrogen, undergoes ozone attack at the phenolic ring, leading to ring opening and loss of estrogenic activity. Rate constants for direct ozonation of many APIs are in the range of 103 to 106 M−1s−1, indicating very fast reactions under typical treatment conditions.

Indirect Oxidation via Hydroxyl Radicals

When solution pH is above 8, or when UV light or hydrogen peroxide is combined with ozone, hydroxyl radical formation dominates. These radicals react with pharmaceuticals at near diffusion-limited rates (108 to 1010 M−1s−1). The advantage of •OH is its non-selectivity, making it effective against even ozone-resistant compounds such as certain beta-blockers (e.g., atenolol) and some X-ray contrast media. However, the presence of radical scavengers (bicarbonate, carbonate, NOM) can consume •OH and reduce treatment efficiency. Proper process optimization balances ozone dosage, contact time, and radical promotion to maximize degradation while minimizing scavenger interference.

Reaction By-Products and Transformation Products

Ozone does not typically achieve complete mineralization (conversion to CO2 and H2O) of pharmaceutical compounds. Instead, it transforms parent molecules into smaller, often more polar, oxygenated intermediates. Some of these transformation products (TPs) may retain biological activity or be more toxic than the original compound. For instance, ozonation of carbamazepine yields several hydroxylated and ring-opened products whose ecotoxicological effects are still under study. Advanced treatment trains often follow ozonation with biological filtration or activated carbon adsorption to remove these TPs. The design of ozonation systems must therefore balance contaminant removal with the potential formation of undesirable by-products, including bromate (when bromide is present in the source water), which is a regulated carcinogen.

Advantages of Ozonation for Pharmaceutical Removal

Ozonation offers a suite of benefits that have made it one of the most widely applied advanced oxidation processes in water treatment, particularly for micropollutant removal.

Exceptional Oxidative Power and Broad Applicability

Ozone and its derivative hydroxyl radicals can degrade a vast spectrum of pharmaceutical compounds, including antibiotics, analgesics, antiepileptics, hormones, and cytostatic drugs. Published studies report removal efficiencies exceeding 90% for many APIs at ozone doses of 0.5–2 mg O3/mg DOC (dissolved organic carbon). For example, a full-scale study at the Wulpen water treatment plant in Belgium achieved >95% removal for 19 of 21 detected pharmaceuticals using ozonation followed by granular activated carbon filtration.

Dual Disinfection Capability

Ozone is a powerful disinfectant that inactivates bacteria, viruses, and protozoan parasites (such as Cryptosporidium parvum and Giardia lamblia) much more effectively than chlorine. This dual function—micropollutant degradation and disinfection—makes ozonation especially valuable for drinking water treatment where both chemical and microbial safety are required. The ability to simultaneously control biological risks reduces the need for additional disinfectant dosing and lowers the formation of chlorinated disinfection by-products downstream.

Minimal Residual Sludge

Unlike adsorption processes (e.g., activated carbon) that produce spent media requiring regeneration or disposal, or membrane filtration that requires management of concentrate streams, ozonation does not generate secondary waste streams. The reaction products are dissolved gases and soluble organic fragments that can be further treated biologically. This feature aligns with the principles of green chemistry and reduces operational complexity.

Improved Water Quality Parameters

Ozonation also enhances aesthetic water quality by oxidizing iron, manganese, and sulfide compounds, which can cause staining and odor issues. It bleaches colored organic compounds (e.g., humic substances), improving water clarity. Additionally, ozone can break down nutrients such as ammonia (in combination with advanced oxidation) and reduce the concentration of certain taste and odor compounds like geosmin and 2-methylisoborneol (MIB).

Challenges and Considerations in Ozonation Implementation

Despite its effectiveness, ozonation is not a universal solution. Several technical and economic factors must be addressed to optimize performance and ensure safe operation.

High Capital and Operating Costs

Ozone generation requires substantial electrical energy—approximately 8–15 kWh per kilogram of ozone produced, depending on feed gas purity and generator efficiency. The cost of oxygen feed systems (if oxygen is used instead of air) adds to capital expenses. For smaller water treatment facilities, these costs can be prohibitive, though the overall lifecycle cost may still be competitive when considering the combined benefits of disinfection and contaminant removal. Energy consumption can be reduced by optimizing ozone dosing and contacting efficiency.

Safety and Handling Issues

Ozone is a toxic and corrosive gas. Exposure limits set by occupational health agencies (e.g., OSHA: 0.1 ppm over 8 hours) require careful monitoring, gas leak detection systems, and personnel training. Ozone contactors must be constructed from ozone-resistant materials (stainless steel, PTFE, or concrete) and sealed to prevent gas escape. Off-gas ozone must be destroyed before atmospheric release, typically via thermal destruct units or catalytic converters. These safety requirements add to infrastructure costs.

Formation of Bromate and Other By-Products

When source water contains bromide ions (Br−), ozone can oxidize them to bromate (BrO3−), a suspected human carcinogen for which the U.S. EPA has established a maximum contaminant level of 10 µg/L. Lowering ozone dosage, adjusting pH, or adding ammonia can inhibit bromate formation but may compromise pharmaceutical removal. The presence of NOM also influences by-product formation; careful control of ozone:DOM ratio is critical. Research into catalytic ozonation using metal oxides or supported catalysts aims to reduce bromate formation while maintaining high oxidation efficiency.

Matrix Effects and Water Chemistry Dependence

The effectiveness of ozonation is highly dependent on water composition. High levels of NOM, carbonate/bicarbonate alkalinity, and suspended solids can consume ozone and hydroxyl radicals, reducing the dose available for pharmaceutical oxidation. pH strongly influences the reaction pathway: at acidic pH, direct molecular ozone predominates, which may be insufficient for ozone-resistant compounds; at basic pH, radical pathways accelerate but so does radical scavenging by carbonate. Temperature also affects ozone solubility and decomposition rate, with higher temperatures reducing ozone concentration in the water. Site-specific treatability studies are essential for proper design.

Comparative Analysis: Ozonation vs. Other Treatment Technologies

Pharmaceutical removal can be achieved by several advanced processes. Understanding the strengths and limitations of ozonation relative to alternatives guides technology selection.

Ozonation vs. Activated Carbon

Granular activated carbon (GAC) and powdered activated carbon (PAC) adsorb many pharmaceuticals, but effectiveness varies by compound polarity and charge. Non-polar, hydrophobic compounds adsorb well; polar, hydrophilic compounds often break through. Ozonation is generally more reliable for a broader range of pharmaceuticals, but does not remove total organic carbon as effectively. Combined ozonation + GAC has been shown to achieve synergistic removal, with ozone transforming recalcitrant molecules into more biodegradable forms that are then adsorbed or biologically degraded in the GAC bed.

Ozonation vs. UV-Based Advanced Oxidation

UV photolysis alone is ineffective for many pharmaceuticals, as they lack sufficient UV absorbance. UV/H2O2 generates hydroxyl radicals and can be effective, but requires high energy input and hydrogen peroxide storage. Ozone-based processes generally achieve higher removal rates for compounds with double bonds or activated aromatics, and can be more cost-effective for large flows. However, UV/H2O2 avoids bromate formation, making it preferable when bromide levels are high. Ozone-UV combinations (O3/UV) also exist, offering enhanced radical production.

Ozonation vs. Membrane Filtration

Reverse osmosis (RO) and nanofiltration (NF) are highly effective at removing pharmaceuticals through size exclusion and electrostatic repulsion, achieving >99% rejection for most compounds. However, membranes produce a concentrated reject stream that requires disposal, and are susceptible to fouling. Ozonation produces no concentrate, but may not achieve complete removal of all compounds. For water reuse applications, RO is often paired with ozonation (as a pre-treatment to reduce fouling or post-treatment for advanced oxidation of trace contaminants).

Integration of Ozonation into Water Treatment Trains

To maximize the benefits of ozonation, it is rarely used as a standalone process. In full-scale installations, ozonation is typically positioned after primary and secondary treatment (for wastewater) or after coagulation/filtration (for drinking water). The sequence can be:

  • Pre-ozonation: Applied early in the treatment train to oxidize iron/manganese, control algae, and reduce taste/odor. However, high ozone demand from NOM reduces efficiency for pharmaceutical removal, so higher doses may be needed.
  • Intermediate or post-ozonation: Applied after particle removal. This is the most common configuration for pharmaceutical abatement. Ozone dose is tuned to target micropollutants while minimizing bromate formation.
  • Ozone + biological activated carbon (BAC): Post-ozonation water is passed through BAC, where biodegradable oxidation by-products are consumed by attached microorganisms. This combination achieves long-term removal of pharmaceuticals and reduces the need for activated carbon regeneration.
  • Ozone + hydrogen peroxide (O3/H2O2): Adding H2O2 promotes hydroxyl radical formation, especially beneficial for recalcitrant compounds. This is often used in advanced oxidation processes for trace contaminant removal.

Case Studies and Research Highlights

Full-Scale Drinking Water Treatment in Switzerland

Switzerland requires at least 80% removal of indicator micropollutants (including pharmaceuticals) in large wastewater treatment plants. Many plants have installed ozonation followed by sand filtration or GAC. For instance, the Wüeri plant operates a 254 kg O3/day system treating 15,000 m³/day. Monitoring showed average removal of 85% for the pharmaceuticals carbamazepine, diclofenac, and sulfamethoxazole at an ozone dose of 0.55 g O3/g DOC. Bromate concentration remained below 5 µg/L due to careful pH control.

Pilot Study on Hospital Wastewater in Germany

Hospital effluents contain high concentrations of antibiotics and contrast media. A pilot ozonation system treating hospital wastewater achieved >95% removal of ciprofloxacin and metoprolol, and 70–90% removal of iodinated contrast media (ICM) at ozone doses of 0.5–9 mg/L. The study emphasized that post-filtration with sand or GAC was essential to remove transformation products, as some ICM by-products showed increased genotoxicity in follow-up tests.

Surface Water Treatment in the United States

The Lake Michigan Water Treatment Plant in Milwaukee operates a 1,100 kg/day ozone system as part of its advanced treatment process. While primarily designed for disinfection, monitoring revealed that ozone reduced concentrations of 18 detected pharmaceuticals by an average of 50–80%, including reductions in the antibiotic trimethoprim (76%), the anticonvulsant primidone (65%), and the analgesic acetaminophen (94%). The plant subsequently added a BAC step to further improve removal.

Future Directions and Emerging Research

Ozonation technology continues to evolve to address challenges of cost, selectivity, and by-product control. Promising avenues include:

Catalytic Ozonation

Incorporating solid catalysts (e.g., metal oxides, zeolites, carbon nanotubes) into the ozonation process can enhance oxidation rates, promote selective radical generation, and suppress bromate formation. Heterogeneous catalytic ozonation has shown up to 50% improvement in pharmaceutical removal compared to ozonation alone for compounds such as ibuprofen and phenacetin.

Process Optimization Using Machine Learning

Real-time monitoring of ozone residual, UV absorbance, fluorescence, or surrogate parameters (like total fluorescence or UV254) allows feed-forward control of ozone dose. Machine learning models trained on water quality data can predict optimal ozone dosage for targeted pharmaceutical removal, minimizing energy and chemical waste. Several pilot projects are exploring this approach for adaptive control.

Combined Ozone + Electrochemical Oxidation

Hybrid systems that integrate ozonation with electrochemical generation of hydrogen peroxide or with anodic oxidation are under investigation. These configurations can achieve almost complete mineralization while reducing energy costs compared to either method alone. Early results show >99% removal of pharmaceuticals like ranitidine and hydrochlorothiazide.

Sonolysis-Ozone Hybrid

Ultrasound irradiation (sonolysis) can enhance ozone mass transfer and promote radical formation via cavitation. The synergy between ultrasound and ozone has been demonstrated for the degradation of antibiotics like amoxicillin, achieving 95% removal within 15 minutes under optimal conditions. Scale-up challenges remain but the approach is promising for niche applications.

Conclusion

Pharmaceutical contamination of water resources represents a complex, growing threat that demands robust treatment solutions. Ozonation, with its powerful oxidation chemistry and long history of safe use in drinking water disinfection, has proven to be one of the most effective technologies for reducing the concentration of active pharmaceutical ingredients in water. Its ability to degrade a wide range of compounds, coupled with simultaneous disinfection and minimal waste generation, makes it an attractive option for both drinking water and wastewater applications. However, successful implementation requires careful consideration of water chemistry, by-product management, and process integration. Advances in catalytic ozonation, real-time process control, and hybrid treatment systems continue to improve both the efficiency and cost-effectiveness of the technology. As regulatory frameworks worldwide push for stricter limits on micropollutants, ozonation—especially when combined with biological post-treatment—will play an increasingly central role in safeguarding water quality and public health. Water utilities, policymakers, and researchers must continue to collaborate on optimizing ozonation systems to ensure that the benefits of this powerful technology are realized without unintended environmental consequences. The journey toward pharmaceutical-free water is challenging, but ozonation provides a proven, scalable pathway toward that goal.

References and Further Reading